BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 3115245)

  • 1. Cellular oncogenes and lymphocyte activation.
    Schneider-Schaulies J; Knauer R; Schimpl A; Wecker E
    Behring Inst Mitt; 1987 Jun; (81):110-9. PubMed ID: 3115245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands.
    Klemsz MJ; Justement LB; Palmer E; Cambier JC
    J Immunol; 1989 Aug; 143(3):1032-9. PubMed ID: 2787345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
    Shipp MA; Reinherz EL
    J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
    Morello D; Lavenu A; Babinet C
    Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes.
    Golay J; Cusmano G; Introna M
    J Immunol; 1992 Jul; 149(1):300-8. PubMed ID: 1376749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression and regulation of c-myb transcription in B6/lpr Lyt-2-, L3T4-T lymphocytes.
    Yokota S; Yuan D; Katagiri T; Eisenberg RA; Cohen PL; Ting JP
    J Immunol; 1987 Oct; 139(8):2810-7. PubMed ID: 3116095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of cellular oncogene expression in mouse lymphocytes. II. Regulation of c-fos and c-myc gene expression.
    Schneider-Schaulies J; Schimpl A; Wecker E
    Eur J Immunol; 1987 May; 17(5):713-8. PubMed ID: 3556196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective T lymphocytes in old mice. Diminished production of mature c-myc RNA after mitogen exposure not attributable to alterations in transcription or RNA stability.
    Buckler AJ; Vie H; Sonenshein GE; Miller RA
    J Immunol; 1988 Apr; 140(7):2442-6. PubMed ID: 3280682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of cellular oncogene expression in mouse lymphocytes. I. Expression of c-myc and c-ras-Ha in T lymphocytes induced by various mitogens.
    Schneider-Schaulies J; Hünig T; Schimpl A; Wecker E
    Eur J Immunol; 1986 Mar; 16(3):312-6. PubMed ID: 3514240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-specific post-transcriptional regulation of c-myc expression in normal and H-2K/human c-myc transgenic mice.
    Morello D; Asselin C; Lavenu A; Marcu KB; Babinet C
    Oncogene; 1989 Aug; 4(8):955-61. PubMed ID: 2668846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proto-oncogene expression in cloned T lymphocytes: mitogens and growth factors induce different patterns of expression.
    Reed JC; Alpers JD; Scherle PA; Hoover RG; Nowell PC; Prystowsky MB
    Oncogene; 1987 May; 1(2):223-8. PubMed ID: 3501855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible cell contact signals regulate early activation gene expression during B-T lymphocyte collaboration.
    Klaus SJ; Parker DC
    J Immunol; 1992 Sep; 149(6):1867-75. PubMed ID: 1387663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of c-fos and c-myc mRNA levels in normal human lymphocytes by calcium ionophore A23187 and phorbol ester.
    Grausz JD; Fradelizi D; Dautry F; Monier R; Lehn P
    Eur J Immunol; 1986 Oct; 16(10):1217-21. PubMed ID: 3095123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogene expression in autoimmune mice.
    Mountz JD; Mushinski JF; Mark GE; Steinberg AD
    J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive activation of oncogenes by chromosomal translocations in B-cell derived tumors.
    Klein G
    AIDS Res; 1986 Dec; 2 Suppl 1():S167-76. PubMed ID: 3030345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
    Heikkila R; Schwab G; Wickstrom E; Loke SL; Pluznik DH; Watt R; Neckers LM
    Nature; 1987 Jul 30-Aug 5; 328(6129):445-9. PubMed ID: 3302722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade.
    Liebermann DA; Hoffman-Liebermann B
    Oncogene; 1989 May; 4(5):583-92. PubMed ID: 2471131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of murine CD8+ lymphocytes: two distinct signals regulate c-myc and interleukin 2 receptor RNA expression.
    Hardt C
    Eur J Immunol; 1987 Dec; 17(12):1711-7. PubMed ID: 3121357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of c-myc and other genes in interleukin 2 regulated CT6 T lymphocytes and their malignant variants.
    Cleveland JL; Rapp UR; Farrar WL
    J Immunol; 1987 May; 138(10):3495-504. PubMed ID: 3106484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenes with potential nuclear function: myc, myb and fos.
    Eisenman RN; Thompson CB
    Cancer Surv; 1986; 5(2):309-27. PubMed ID: 3779660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.